Droperidol Analgesia for Opioid-Tolerant Patients (Q37787506)

23 August 2017

title

Droperidol analgesia for opioid-tolerant patients (English)

1 reference

23 August 2017

Droperidol Analgesia for Opioid-Tolerant Patients (English)

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

11 July 2024

0 references

Gal Ozery

3

1 reference

23 August 2017

John R. Richards

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20832967

11 July 2024

Irina N. Richards

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20832967

11 July 2024

Robert W. Derlet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:20832967

11 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20832967

11 July 2024

publication date

15 September 2010

1 reference

full work available at URL

23 August 2017

https://api.elsevier.com/content/article/PII:S0736467910005573?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

https://api.elsevier.com/content/article/PII:S0736467910005573?httpAccept=text/plain

11 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Journal of Emergency Medicine

11 July 2024

published in

1 reference

23 August 2017

volume

41

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

389-396

1 reference

Management of chronic pain in the acute care setting

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Epidemiologic analysis of an urban, public emergency department's frequent users

11 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Chronic migraineurs: an important subgroup of patients who visit emergency departments frequently

11 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Is there genetic polymorphism evidence for individual human sensitivity to opiates?

11 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Pharmacogenetics of opioids

11 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Opioids depress cortical centers responsible for the volitional control of respiration.

11 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Overcrowding in the nation's emergency departments: complex causes and disturbing effects

11 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

The drug-seeking patient in the emergency room

11 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Prescription opioid abuse in the emergency department

11 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Opioid Therapy for Chronic Pain

11 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Effectiveness of nonnarcotic protocol for the treatment of acute exacerbations of chronic nonmalignant pain

11 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

The molecular dynamics of pain control

11 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Role of central dopamine in pain and analgesia

11 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum

11 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity

11 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Opioid abuse and brain gene expression

11 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Alteration of D1 and D2 dopaminergic receptor kinetics in specific rat brain regions following repeated administration of opiates

11 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Differential effects of dopamine on pain-related electric activities in normal rats and morphinistic rats

11 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Morphine dependence changes the role of droperidol on pain-related electric activities in caudate nucleus

11 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Fibromyalgia patients show an abnormal dopamine response to pain

11 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Changes in gray matter density in fibromyalgia: correlation with dopamine metabolism

11 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Voxel-based morphometry reveals gray matter abnormalities in migraine.

11 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

The pharmacology of dehydrobenzperidol, a new potent and short acting neuroleptic agent chemically related to Haloperidol

11 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Neuroleptic binding to human brain receptors: relation to clinical effects

11 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol suppresses spontaneous electrical activity in neurons cultured from ventral midbrain. Implications for neuroleptanesthesia

11 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Effects of droperidol on the vasoconstriction produced by noradrenaline, histamine, sympathetic nerve stimulation and potassium ions in the isolated rabbit auricular artery

11 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol inhibits tracheal contraction induced by serotonin, histamine or carbachol in guinea pigs

11 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Anticholinesterase activity of some butyrophenones

11 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Has droperidol an atropinic effect?

11 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

The effect of biogenic amine modifiers on morphine analgesia and its antagonism by naloxone

11 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Further electrophysiological evidence for the GABA-like effect of droperidol in the Purkinje cells of the cat cerebellum

11 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol inhibits GABA(A) and neuronal nicotinic receptor activation

11 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

The effect of droperidol on mammalian non-myelinated nerve fibres

11 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Differential block of fast and slow inactivating tetrodotoxin-sensitive sodium channels by droperidol in spinal dorsal horn neurons

11 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Suppression of potassium conductance by droperidol has influence on excitability of spinal sensory neurons

11 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Molecular actions of droperidol on human CNS ion channels

11 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Effect of droperidol, aminazine and diazepam on the analgesic activity of leucine-enkephalin

11 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Effects of droperidol on the biosynthesis and release of endogenous opioid peptides in guinea-pig ileum

11 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Haloperidol treatment increases the biosynthesis and release of endorphins in guinea-pig ileum.

11 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Peroral management of chronic pain by means of bezitramide (R 4845), a long-acting analgesic, and droperidol (R 4749), a neuroleptic. A multicentric pilot-study

11 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Experience with bezitramide and droperidol in the treatment of severe chronic pain

11 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol Treatment of Status Migrainosus and Refractory Migraine

11 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol vs. prochlorperazine for benign headaches in the emergency department

11 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol vs prochlorperazine for the treatment of acute headache

11 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol for acute migraine headache

11 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache

11 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial

11 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Olanzapine versus droperidol for the treatment of primary headache in the emergency department

11 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol analgesia in organic headache

11 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

A report on clinical uses of droperidol and fentanyl

11 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Patient-controlled analgesia with a mixture of morphine and droperidol

11 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Morphine sparing with droperidol in patient-controlled analgesia

11 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Preoperative droperidol improved postoperative pain relief in patients undergoing rotator-cuff repair during general anesthesia using intravenous morphine

11 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

High-dose ondansetron regimen vs droperidol for morphine patient-controlled analgesia.

11 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Potentiation of epidural opioids with epidural droperidol. A one year retrospective study

11 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Continuous epidural droperidol for postoperative pain

11 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Epidural droperidol and morphine for postoperative pain

11 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Epidural droperidol reduces the side effects and duration of analgesia of epidural sufentanil

11 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Additional droperidol, not butorphanol, augments epidural fentanyl analgesia following anorectal surgery

11 July 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Minidose lidocaine-fentanyl spinal anesthesia in ambulatory surgery: prophylactic nalbuphine versus nalbuphine plus droperidol

11 July 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Comparison of tramadol and tramadol/droperidol mixture for patient-controlled analgesia

11 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

The addition of droperidol or clonidine to epidural tramadol shortens onset time and increases duration of postoperative analgesia

11 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Comparison of fentanyl and droperidol mixture (neuroleptanalgesia II) with morphine on clinical outcomes in unstable angina patients

11 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol

11 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Continuous droperidol infusion for management of agitated delirium in an intensive care unit.

11 July 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol and 5-HT3-receptor antagonists, alone or in combination, for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomised controlled trials

11 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol and diphenhydramine in the management of hyperemesis gravidarum

11 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral vertigo in the emergency department: a randomized clinical trial

11 July 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Absorption, Metabolism and Excretion of Droperidol by Human Subjects Folloiwing Intramuscular and Intravenous Administration

11 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Akathisia following low-dose droperidol for antiemesis in day-case patients

11 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Antiemetics in the ED: a randomized controlled trial comparing 3 common agents.

11 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Neuroleptic-induced movement disorders: an overview

11 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Patient-controlled analgesia with morphine and droperidol following caesarean section under spinal anaesthesia

11 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

The effect of IM droperidol on driving performance

11 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

A randomized trial of diphenhydramine as prophylaxis against metoclopramide-induced akathisia in nauseated emergency department patients

11 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Intravenous administration of prochlorperazine by 15-minute infusion versus 2-minute bolus does not affect the incidence of akathisia: a prospective, randomized, controlled trial

11 July 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Slow infusion for the prevention of akathisia induced by prochlorperazine: a randomized controlled trial.

11 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current

11 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Effect of low-dose droperidol on the QT interval during and after general anesthesia: a placebo-controlled study.

11 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Con: The black box warning on droperidol should not be removed (but should be clarified!).

11 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Droperidol in the Emergency Department: is it safe?

11 July 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Safety of droperidol in behavioural emergencies

11 July 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

A retrospective review of the use and safety of droperidol in a large, high-risk, inner-city emergency department patient population

11 July 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Unexpected cardiovascular deaths are rare with therapeutic doses of droperidol

11 July 2024

100

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases.

11 July 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?

11 July 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.JEMERMED.2010.07.005

11 July 2024

Identifiers

1 reference

23 August 2017

1 reference